DE1445882A1 - Verfahren zur Herstellung von Pyridinderivaten - Google Patents

Verfahren zur Herstellung von Pyridinderivaten

Info

Publication number
DE1445882A1
DE1445882A1 DE19631445882 DE1445882A DE1445882A1 DE 1445882 A1 DE1445882 A1 DE 1445882A1 DE 19631445882 DE19631445882 DE 19631445882 DE 1445882 A DE1445882 A DE 1445882A DE 1445882 A1 DE1445882 A1 DE 1445882A1
Authority
DE
Germany
Prior art keywords
formula
compound
condensation
acid
dioxepin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19631445882
Other languages
German (de)
English (en)
Inventor
Walter Kimel
Willy Leimgruber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1445882A1 publication Critical patent/DE1445882A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/42—One oxygen atom attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Air Transport Of Granular Materials (AREA)
DE19631445882 1962-11-29 1963-11-12 Verfahren zur Herstellung von Pyridinderivaten Pending DE1445882A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US241019A US3250778A (en) 1962-11-29 1962-11-29 Intermediates for and synthesis of vitamin b and related compounds

Publications (1)

Publication Number Publication Date
DE1445882A1 true DE1445882A1 (de) 1968-11-28

Family

ID=22908910

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19631445882 Pending DE1445882A1 (de) 1962-11-29 1963-11-12 Verfahren zur Herstellung von Pyridinderivaten

Country Status (9)

Country Link
US (1) US3250778A (enExample)
BR (1) BR6354482D0 (enExample)
CH (1) CH427795A (enExample)
DE (1) DE1445882A1 (enExample)
DK (2) DK109037C (enExample)
ES (1) ES293991A1 (enExample)
GB (2) GB1013893A (enExample)
NO (1) NO122836B (enExample)
SE (1) SE308522B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058774A1 (de) * 2002-12-27 2004-07-15 Basf Aktiengesellschaft Verfahren zur herstellung von pyridoxin oder seines säureadditionssalzes

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451137A (de) * 1964-05-27 1968-05-15 Hoffmann La Roche Verfahren zur Herstellung von Pyridinderivaten
US3410856A (en) * 1965-10-21 1968-11-12 Merck & Co Inc Intermediates and process for preparing vitamin b6
US3429897A (en) * 1965-10-21 1969-02-25 Merck & Co Inc 3,6-dihydro-1,2-dioxin and its method of production
US3365461A (en) * 1965-10-21 1968-01-23 Merck & Co Inc Process for preparing pyridoxine
US3408359A (en) * 1965-10-21 1968-10-29 Merck & Co Inc 7-methyl-8-hydroxy-1, 4-dihydro-o-dioxin(4, 5-c)pyridine
US3364226A (en) * 1965-10-21 1968-01-16 Merck & Co Inc Method for preparing pyridoxine and intermediates therefor
US3525749A (en) * 1969-03-19 1970-08-25 Merck & Co Inc Certain 1,3-dioxepino-(5,6-c)-pyridines
US4011231A (en) * 1975-10-03 1977-03-08 Pfizer Inc. 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate
WO2005049618A1 (en) * 2003-11-19 2005-06-02 Dsm Ip Assets B.V. Manufacture of vitamin b6
CN109956899B (zh) * 2017-12-14 2021-01-22 新发药业有限公司 一种维生素b6的制备方法
CN114149442A (zh) * 2021-12-08 2022-03-08 华中药业股份有限公司 一种杂质ts-3b的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260261A (en) * 1941-10-21 Cyclic ketals and process for
US2312743A (en) * 1939-12-01 1943-03-02 Standard Oil Dev Co Alkoxy meta-dioxanes
US2520038A (en) * 1948-04-14 1950-08-22 American Cyanamid Co Process for preparing pyridoxine hydrochloride
US2875207A (en) * 1953-11-30 1959-02-24 Sadolin & Holmblad As Process for the preparation of vitamin b6, intermediates employed therein, and processes of preparing the same
US2870097A (en) * 1955-07-01 1959-01-20 Du Pont Process for the preparation of polymeric acetals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058774A1 (de) * 2002-12-27 2004-07-15 Basf Aktiengesellschaft Verfahren zur herstellung von pyridoxin oder seines säureadditionssalzes

Also Published As

Publication number Publication date
DK115330B (da) 1969-09-29
NO122836B (enExample) 1971-08-23
DK109037C (da) 1968-03-11
US3250778A (en) 1966-05-10
CH427795A (de) 1967-01-15
GB1013893A (en) 1965-12-22
SE308522B (enExample) 1969-02-17
GB1013894A (en) 1965-12-22
BR6354482D0 (pt) 1973-07-03
ES293991A1 (es) 1964-05-16

Similar Documents

Publication Publication Date Title
DE1445882A1 (de) Verfahren zur Herstellung von Pyridinderivaten
DE2715080A1 (de) Verfahren zur herstellung von cyclopentenon-derivaten
DE2651773A1 (de) Neue derivate des daunorubicins, ihre herstellung und die sie enthaltenden zusammensetzungen
DE1956237A1 (de) Spiro-pyrrolizidon-oxindole
DE2502504C3 (de) Phenothiazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2608932A1 (de) Verfahren zur herstellung eines 3-oxy-4h-pyran-4-on-derivats
DE1618825C3 (de) 3,5-Diketale von 3,5,17-Trioxo-13beta-alkyl-4,5,-seco-gonanen und Verfahren zu ihrer Herstellung
DE1445882C (de) Verfahren zur Herstellung von Pyn dindenvaten
AT250362B (de) Verfahren zur Herstellung von neuen Pyridinderivaten
DE69229017T2 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
DE2221123C2 (de) Reserpsäurederivate, Verfahren zu deren Herstellung und Arzneimittel
DE1445882B (de) Verfahren zur Herstellung von Pyridinderivaten
EP0175264B1 (de) Verfahren zur Herstellung von 2-Amino-3-cyano-5-dialkoxymethyl-pyrazinen und Zwischenprodukte für dieses Verfahren
AT250356B (de) Verfahren zur Herstellung von Pyridinderivaten
DE3109532C2 (de) Stereoisomere 1,4;3,6-Dianhydro-2,5-diazido-2,5-didesoxyhexite, Verfahren zur Herstellung derselben und diese Verbindungen enthaltende Arzneimittel
DE3012667A1 (de) Verfahren zur herstellung von derivaten von 6- beta -amidinopenicillansaeure
CH648018A5 (de) Verfahren zur herstellung von omega-indol-3-yl-alkanol-verbindungen.
DE1965963C (de) Sterroidoxazolidine und Steroidoxazolidinoxazine und Verfahren zu ihrer Herstellung. Ausscheidung aus: 1921778
DE3136987A1 (de) Verfahren zur herstellung von 3-keto-5-oxy-cyclopentenen
DE2404924B2 (de) 1,6-Dimethyl-1 Oalpha-methoxy-8-hydroxyäthylergolinester, Verfahren zu ihrer Herstellung und pharmazeutische Mittel
DE1695695C3 (de) Verfahren zur Herstellung von 2-Aminofuro eckige Klammer auf 2,3-d eckige Klammer zu thiazolen
DE2642598A1 (de) Neue isoindolinderivate, deren herstellung und diese enthaltende zusammensetzungen
DE1418945C3 (de) Verfahren zur Herstellung von 16 alpha Methyl 17alpha hydroxy 20 oxo pregnandenvaten
AT251579B (de) Verfahren zur Herstellung von Pyridinderivaten
DE1062703B (de) Verfahren zur Herstellung von Scopolin, seinen Estern und AEthern sowie deren quartaeren Ammonium-verbindungen

Legal Events

Date Code Title Description
E77 Valid patent as to the heymanns-index 1977